| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.00088 | 1 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.00079 | 1 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | -0.00075 | 1 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.00076 | 1 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | 0.00077 | 1 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.00067 | 1 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | -0.00079 | 1 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.0007 | 1 |